The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
Open accessAbstract
An increased circulating level of fibroblast growth factor 23 (FGF23) is an independent risk factor for mortality, cardiovascular disease, and progression of chronic kidney disease (CKD), but its role in transplant allograft and patient survival is unknown. We tested the hypothesis that increased FGF23 is an independent risk factor for all-cause mortality and allograft loss in a prospective cohort of 984 stable kidney transplant recipients. At enrollment, estimated GFR (eGFR) was 51 ± 21 ml/min per 1.73 m(2) and median C-terminal FGF23 was 28 RU/ml (interquartile range, 20 to 43 RU/ml). Higher FGF23 levels independently associated with increased risk of the composite outcome of all-cause mortality and allograft loss (full model hazard ratio: 1.46 per SD increase in logFGF23, 95% confidence interval: 1.28 to 1.68, P<0.001). The results were similar for each component of the composite outcome and in all sensitivity analyses, including prespecified analyses of patients with baseline eGFR of 30 to 90 ml/min per 1.73 m(2). In contrast, other measures of phosphorus metabolism, including serum phosphate and parathyroid hormone (PTH) levels, did not consistently associate with outcomes. We conclude that a high (or elevated) FGF23 is an independent risk factor for death and allograft loss in kidney transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationSerum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Self-citationDhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Strategies to Improve Long-Term Outcomes after Renal Transplantation
Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., & Cosimi, A. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011295 · Cited by 844
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Self-citationActivated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
Self-citationFliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
Risk of Hip Fracture Among Dialysis and Renal Transplant Recipients
Ball, A. M. (2002) · JAMA · doi:10.1001/jama.288.23.3014 · Cited by 441
Phosphorus Binders and Survival on Hemodialysis
Isakova, T., Gutie[Combining Acute Accent]rrez, O. M., Chang, Y., Shah, A., Tamez, H., Smith, K., Thadhani, R., & Wolf, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060609 · Cited by 375
Self-citationEarly Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Oliveira, R. B., Cancela, A. L. E., Graciolli, F. G., Dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05420709 · Cited by 357
Hasegawa, H., Nagano, N., Urakawa, I., Yamazaki, Y., Iijima, K., Fujita, T., Yamashita, T., Fukumoto, S., & Shimada, T. (2010) · Kidney International · doi:10.1038/ki.2010.313 · Cited by 341
Mirza, M. A. I., Larsson, A., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Wolf, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121293 · Cited by 308
Self-citationRelation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Tonelli, M., Curhan, G., Pfeffer, M., Sacks, F., Thadhani, R., Melamed, M. L., Wiebe, N., & Muntner, P. (2009) · Circulation · doi:10.1161/circulationaha.109.851873 · Cited by 280
Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling-Perry, K., Wolf, M., Salusky, I. B., & Jüppner, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1603 · Cited by 229
Self-citationRelationship between circulating FGF23 and total body atherosclerosis in the community
Mirza, M. A. I., Hansen, T., Johansson, L., Ahlström, H., Larsson, A., Lind, L., & Larsson, T. E. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp205 · Cited by 223
Proteinuria After Kidney Transplantation, Relationship to Allograft Histology and Survival
Amer, H., Filder, M. E., Myslak, M., Morales, P., Kremers, W. K., Larson, T. S., Stegall, M. D., & Cosio, F. G. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02006.x · Cited by 204
Seiler, S., Reichart, B., Roth, D., Seibert, E., Fliser, D., & Heine, G. H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq309 · Cited by 198
The changing causes of graft loss and death after kidney transplantation
Howard, R. J., Patton, P. R., Reed, A. I., Hemming, A. W., Van der Werf, W. J., Pfaff, W. W., Srinivas, T. R., & Scornik, J. C. (2002) · Transplantation · doi:10.1097/00007890-200206270-00013 · Cited by 195
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Bhan, I., Shah, A., Holmes, J., Isakova, T., Gutierrez, O., Burnett, S.-A., Jüppner, H., & Wolf, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001788 · Cited by 194
Self-citationLong-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis
Kriz, W., Hähnel, B., Rösener, S., & Elger, M. (1995) · Kidney International · doi:10.1038/ki.1995.433 · Cited by 191
FGF-23: More than a regulator of renal phosphate handling?
Jüppner, H., Wolf, M. S., & Salusky, I. B. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.170 · Cited by 180
Self-citationEvenepoel, P., Naesens, M., Claes, K., Kuypers, D., & Vanrenterghem, Y. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01753.x · Cited by 173
Kovesdy, C. P., Ahmadzadeh, S., Anderson, J. E., & Kalantar-Zadeh, K. (2008) · Kidney International · doi:10.1038/ki.2008.64 · Cited by 169
Self-citationEvenepoel, P., Meijers, B. K. I., de Jonge, H., Naesens, M., Bammens, B., Claes, K. J., Kuypers, D. R. J., & Vanrenterghem, Y. F. C. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01310308 · Cited by 162
Baseline Comorbidity in Kidney Transplant Recipients: A Comparison of Comorbidity Indices
Jassal, S. V., Schaubel, D. E., & Fenton, S. S. A. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.03.006 · Cited by 153
Floege, J., Kriz, W., Schulze, M., Susani, M., Kerjaschki, D., Mooney, A. F., Couser, W. G., & Koch, K. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118351 · Cited by 145
Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study
Ix, J. H., Shlipak, M. G., Wassel, C. L., & Whooley, M. A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp699 · Cited by 133
Bacchetta, J., Dubourg, L. D., Harambat, J., Ranchin, B., Abou-Jaoudé, P., Arnaud, S., Carlier, M.-C., Richard, M., & Cochat, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1576 · Cited by 123
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Isakova, T., Gutiérrez, O. M., & Wolf, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.246 · Cited by 103
Self-citationManghat, P., Fraser, W. D., Wierzbicki, A. S., Fogelman, I., Goldsmith, D. J. A., & Hampson, G. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1142-4 · Cited by 94
Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients
Connolly, G. M., Cunningham, R., Mcnamee, P. T., Young, I. S., & Maxwell, A. P. (2009) · Transplantation · doi:10.1097/tp.0b013e31819cd122 · Cited by 74
The Antisenescence Protein Klotho Is Necessary for FGF23-Induced Phosphaturia
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2007) · Journal of the American Society of Nephrology · doi:10.1681/01.asn.0000926868.48235.3d · Cited by 63
Amuchastegui, S., Daniel, K. C., & Adorini, L. (2005) · Transplantation · doi:10.1097/01.tp.0000164619.49828.7a · Cited by 45
Schäeffner, E., Födinger, M., Kramar, R., et al. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00436.x · Cited by 43
Mathieu, C., & Jafari, M. (2006) · Clinical Nephrology · doi:10.5414/cnp66275 · Cited by 32
Cited by
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
David, V., Martin, A., Isakova, T., Spaulding, C., Qi, L., Ramirez, V., Zumbrennen-Bullough, K. B., Sun, C. C., Lin, H. Y., Babitt, J. L., et al. (2016) · Kidney International · doi:10.1038/ki.2015.290 · Cited by 494
Self-citationClinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Self-citationIx, J. H., Katz, R., Kestenbaum, B. R., de Boer, I. H., Chonchol, M., Mukamal, K. J., Rifkin, D., Siscovick, D. S., Sarnak, M. J., & Shlipak, M. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.040 · Cited by 324
Metadata
- Authors
- Wolf, M., Molnar, M. Z., Amaral, A. P., Czira, M. E., Rudas, A., Ujszaszi, A., Kiss, I., Rosivall, L., Kosa, J., Lakatos, P., Kovesdy, C. P., & Mucsi, I.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2011-05
- Volume
- 22
- Issue
- 5
- Pages
- 956-966
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2111899789
- Cited by
- 290
- References
- 46
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.